| Risankizumab | Adalimumab | Mean difference (95% confidence interval) |
---|---|---|---|
Cost of treatment (USD), mean ± SD | 16638.33 ± 5086.63 | 10767.40 ± 1008.35 | 5870.93(4772.39– 7865.18) |
Difference in PASI (%) | 87.373 ± 25.938 | 74.499 ± 36.143 | 12.88(1.271–24.934) |